This website is designed to display best with your monitor set at screen resolution 1024 x 768 pixels, but will generally display with minimal
scrolling at 800 x 600 pixels. Cascading Style Sheet (CSS) are used to set the colour and size of the test within each page.
Some user might find screen test easier to read by increasing the size at which text is displayed. To do this, please adjust your browser
settings manually and follow the instructions below:
DevelopAKUre is a series of major international clinical trials, run by a consortium of 12 European partners. It aims to study a potential new drug, called nitisinone, and assess its potential effectiveness in treating the rare disease, alkaptonuria (AKU).
DevelopAKUre is co-funded by a grant from the European Commission. This website is run by a UK patient group, the AKU Society. Learn more about AKU on the AKU Society's What is AKU page.
In today’s blog Chief investigator Prof. Ranganath reinforces the need for SONIA 2 pat.. ...more